These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 2177769)
1. High urinary cAMP in hypertensives despite careful drug treatment--an epidemiological study from the Dalby population. Nilsson P; Lindholm L; Winther K; Scherstén B; Hesch RD J Intern Med; 1990 Dec; 228(6):603-9. PubMed ID: 2177769 [TBL] [Abstract][Full Text] [Related]
2. Hyperinsulinaemia and other metabolic disturbances in well-controlled hypertensive men and women: an epidemiological study of the Dalby population. Nilsson P; Lindholm L; Scherstén B J Hypertens; 1990 Oct; 8(10):953-9. PubMed ID: 2174949 [TBL] [Abstract][Full Text] [Related]
3. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension. Papagalanis ND; Skopelitis P; Kourti A; Kostogianni G; Karabatsos A; Gennadiou M; Thomas S; Samartzis M; Mountokalakis T Nephron; 1991; 59(2):226-31. PubMed ID: 1659670 [TBL] [Abstract][Full Text] [Related]
4. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. Pak CY; Oata M; Lawrence EC; Snyder W J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891 [TBL] [Abstract][Full Text] [Related]
5. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. Kukreja SC; Shemerdiak WP; Lad TE; Johnson PA J Clin Endocrinol Metab; 1980 Jul; 51(1):167-9. PubMed ID: 6247360 [TBL] [Abstract][Full Text] [Related]
6. Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Frenkel Y; Barkai G; Mashiach S; Dolev E; Zimlichman R; Weiss M Obstet Gynecol; 1991 May; 77(5):689-91. PubMed ID: 1849625 [TBL] [Abstract][Full Text] [Related]
7. High remaining risk in poorly treated hypertension: the 'rule of halves' still exists. Weinehall L; Ohgren B; Persson M; Stegmayr B; Boman K; Hallmans G; Lindholm LH J Hypertens; 2002 Oct; 20(10):2081-8. PubMed ID: 12359988 [TBL] [Abstract][Full Text] [Related]
9. I. PTH and U. cAMP during mineralocorticoid hypertension in the rat. Berthelot A; Desplan C; Pernot F; Gairard A Horm Metab Res; 1978 Jan; 10(1):83-4. PubMed ID: 204568 [No Abstract] [Full Text] [Related]
10. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. Marcus R; Madvig P; Young G J Clin Endocrinol Metab; 1984 Feb; 58(2):223-30. PubMed ID: 6319444 [TBL] [Abstract][Full Text] [Related]
11. Ambulatory blood pressure monitoring and progression in patients with IgA nephropathy. Csiky B; Kovács T; Wágner L; Vass T; Nagy J Nephrol Dial Transplant; 1999 Jan; 14(1):86-90. PubMed ID: 10052483 [TBL] [Abstract][Full Text] [Related]
12. Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) Cohort Study. Ishikawa S; Shibano Y; Asai Y; Kario K; Kayaba K; Kajii E Hypertens Res; 2007 Jul; 30(7):643-9. PubMed ID: 17785933 [TBL] [Abstract][Full Text] [Related]
13. Pseudohypoparathyroidism and idiopathic hypoparathyroidism: relationship between serum calcium and parathyroid hormone levels and urinary cyclic adenosine-3',5'-monophosphate response to parathyroid extract. Werder EA; Fischer JA; Illig R; Kind HP; Bernasconi S; Fanconi A; Prader A J Clin Endocrinol Metab; 1978 Jun; 46(6):872-9. PubMed ID: 233700 [TBL] [Abstract][Full Text] [Related]
14. The effect of an intravenous calcium load on serum total and ionized calcium in normotensive and hypertensive subjects. Cirillo M; Strazzullo P; Galletti F; Siani A; Nunziata V J Clin Hypertens; 1985 Mar; 1(1):30-4. PubMed ID: 3014074 [TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH. Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082 [TBL] [Abstract][Full Text] [Related]
16. Abnormalities of calcium metabolism in essential hypertension. Strazzullo P; Nunziata V; Cirillo M; Giannattasio R; Ferrara LA; Mattioli PL; Mancini M Clin Sci (Lond); 1983 Aug; 65(2):137-41. PubMed ID: 6305548 [TBL] [Abstract][Full Text] [Related]
17. Relationship of vitamin D and parathyroid hormone with the nocturnal blood pressure decline in hypertension. Karadag MK; Secen O Blood Press Monit; 2017 Dec; 22(6):322-327. PubMed ID: 28926360 [TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog. Fox J; Heath H Endocrinology; 1980 Dec; 107(6):2124-5. PubMed ID: 6253291 [TBL] [Abstract][Full Text] [Related]
19. Aminoaciduria of vitamin D deficiency is independent of PTH levels and urinary cyclic AMP. Dabbagh S; Chesney R; Gusowski N; Mathews MC; Padilla M; Theissen M; Slatopolsky E Miner Electrolyte Metab; 1989; 15(4):221-32. PubMed ID: 2548072 [TBL] [Abstract][Full Text] [Related]
20. Effect of saline infusion on urinary calcium excretion in essential hypertension. Nakamura T; Ichikawa S; Sakamaki T; Sato K; Fujie M; Kurashina T; Kato T; Aizawa F; Murata K Am J Hypertens; 1991 Feb; 4(2 Pt 1):113-8. PubMed ID: 1826996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]